Fatigue, Sleep Disorders and Endocrine Abnormalities in TBI Patients
The Relationship Between Fatigue, Sleep Disorders and Endocrine Abnormalities Following Traumatic Brain Injury
Study Overview
Status
Status
Conditions
Conditions
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Anthony Lequerica, Ph.D.
- Phone Number: 973-324-3551
- Email: alequerica@kesslerfoundation.net
Study Contact Backup
- Name: Alexandria Muench
- Phone Number: 973-324-3540
- Email: amuench@kesslerfoundation.net
Study Locations
-
-
New Jersey
-
West Orange, New Jersey, United States, 07052
- Recruiting
- Kessler Foundation Research Center
-
Contact:
- Anthony Lequerica, Ph.D.
- Phone Number: 973-324-3551
- Email: alequerica@kesslerfoundation.net
-
Contact:
- Alexandria Muench
- Phone Number: 973-324-3540
- Email: amuench@kesslerfoundation.net
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Having moderate to severe TBI at least 3 months prior to enrollment. This can be demonstrated by a history of loss of consciousness, amnesia or another neurologic deficit after brain injury
- Be between the ages of 18 and 70 years
Exclusion Criteria:
- History of prior TBI, stroke, seizures, severe psychiatric disturbances (i.e., those known to influence memory performance, such as schizophrenia, bipolar disorder), or drug abuse will be excluded.
- Pregnant, nursing, or planning pregnancy during the study period.
- Dementia
- Other neurological conditions which are associated with aging and known to cause fatigue (e.g. Parkinson's Disease)
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
|---|
|
TBI
Patients with moderate to severe TBI
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
To further study the incidence of fatigue and endocrine abnormalities in an outpatient TBI population
Time Frame: 1 year
|
1 year
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
To study the relationship between fatigue and endocrine abnormalities
Time Frame: 1 year
|
1 year
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- R45303
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.